RxDoctor Payments Data

Christine Go, PA

Physician Assistant · Clinton Township, MINPI 1356695936

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.8%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Johnson & Johnson at 26.7% of the total. Among physician assistant clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,192in general payments, 2019–2025

Across 314 payments — averaging $64.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$5K
  • UCB, Inc.$3K
  • Sanofi$2K
  • E.r. Squibb & Sons, L.L.C.$2K
  • Sun Pharmaceutical Industries Inc.$1K
  • Arcutis Biotherapeutics, Inc.$1K
  • plus $6K from 25 others

What the payments were for

  • Consulting fees$10,87354%
  • Speaking & faculty fees$8754%
  • Travel & lodging$4292%
  • Food & beverage$7,59538%
  • Education$4202%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,192 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$120,489
Medicare patients
421
Services billed
2,012

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast21$98,815
Clobetasol Propionate113$2,706
Fluorouracil40$2,323
Ketoconazole150$1,962
Tacrolimus21$1,814
Metronidazole41$1,082
Triamcinolone Acetonide141$787
Hydrocortisone117$632
Doxycycline Hyclate34$461
Betamethasone Dipropionate13$452
Clindamycin Phosphate14$426
Mupirocin58$311
Cephalexin20$262
Ammonium Lactate22$259
Fluticasone Propionate21$253

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$435$98,81521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Clinton Township

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →